Dear fellow researchers,
I am working on a project to globally determine the phosphorylation quantitative profiles of cisplatin-induced apoptosis in Jurkat T-cells. I have 4 biological replicates of control against 4 treated samples. These samples are then digested, performed phosphopeptide enrichment, and analyzed by LC-MS/MS. When comparing phosphoproteins in control against treated samples, the data showed that cell cycle/mitosis proteins are enriched amongst down-regulated proteins in cisplatin-treated cells. While the upregulated proteins are enriched in proteins of MAPK signaling pathway.
Since MAPK signaling pathway with three MAPK families (ERK, JNK/SAPK, and p38 MAPK) is closely associated with cell proliferation, differentiation, development, inflammation, apoptosis, and stress response.
Because this is cisplatin-induced apoptosis in Jurkat T-cells, then MAPK involved in inflammation, apoptosis, and stress response is quite expected. But so does cell cycle/mitosis.
In addition, phosphorylated transcription factor c-JUN has been found to be up-regulated in cisplatin-treated compared to control samples. The western blots results showed that both phosphorylated and un-phosphorylated versions of c-JUN were upregulated.
Un-phosphorylated c-JUN is required for maintaining sufficient cyclin D1 kinase activity and allowing cell cycle progression. While phosphorylated S63/S73 c-JUN is required for the cooperation of c-JUN with NF-κB to prevent apoptosis induced by TNFα. This means that c-JUN regulates cell cycle progression and apoptosis through two separate mechanisms. Either ways, increased expression of c-JUN is closely related to cell cycle/mitosis.
However, when comparing phosphoproteins in control against treated samples, the data showed that cell cycle/mitosis proteins are enriched amongst down-regulated proteins in cisplatin-treated cells. Does anyone know why this is the case?
Thank you so much for your help. I really appreciate it.